Drug profile · INN
naloxegol oxalate
MOVANTIK
naloxegol oxalate (MOVANTIK) is a mu opioid receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — naloxegol oxalate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 2
- Programs
- 0
- Data quality
- 0.84
Quick answer
naloxegol oxalate (MOVANTIK) is a mu opioid receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Mu opioid receptor antagonist
Primary target: Mu-type opioid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Related patents
Frequently asked questions
What is naloxegol oxalate?
naloxegol oxalate (MOVANTIK) is a mu opioid receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for naloxegol oxalate?
MOVANTIK is a marketed brand name for naloxegol oxalate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of naloxegol oxalate?
naloxegol oxalate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.